Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
71,42 USD | +2,19% | +2,19% | 0,00% |
Vakgebied
Aantal werknemers: 58
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 196 | 100,0 % | 131 | 100,0 % | -33,09% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 196 | 100,0 % | 131 | 100,0 % | -33,09% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Todd Davis
CEO | Chief Executive Officer | 63 | 01-03-07 |
Octavio Espinoza
DFI | Director of Finance/CFO | 53 | 01-11-22 |
President | 49 | 06-08-15 | |
Andrew Reardon
LAW | General Counsel | 49 | 01-01-22 |
Corporate Officer/Principal | - | 20/02 | |
Karen Reeves
PRN | Corporate Officer/Principal | - | 20/02 |
Human Resources Officer | - | 01-12-94 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Kozarich
CHM | Chairman | 74 | 01-03-03 |
John LaMattina
BRD | Director/Board Member | 74 | 01-02-11 |
Stephen Sabba
BRD | Director/Board Member | 64 | 04-08-08 |
Jason Aryeh
BRD | Director/Board Member | 56 | 27-09-06 |
Todd Davis
CEO | Chief Executive Officer | 63 | 01-03-07 |
Nancy Ryan Gray
BRD | Director/Board Member | 64 | 18-08-17 |
Director/Board Member | 55 | 26-09-23 | |
Jason Haas
BRD | Director/Board Member | 56 | 29-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 17 958 354 | 17 521 961 ( 97,57 %) | 0 | 97,57 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
3 616 077 | 3.31% | 296 518 314 $ |
Bedrijfsgegevens
Ligand Pharmaceuticals, Inc.
555 Heritage Drive Suite 200
33458, Jupiter
+858 550 7500
http://www.ligand.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
0,00% | 1,26 mld. | |
+33,25% | 704 mld. | |
+28,59% | 577 mld. | |
-3,55% | 348 mld. | |
+18,16% | 327 mld. | |
+4,36% | 288 mld. | |
+14,81% | 234 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-3,69% | 147 mld. |
- Beurs
- Aandelen
- Koers LGND
- Onderneming Ligand Pharmaceuticals Incorporated